Home Healthcare Demand Will Spur Capacity Expansion
Aveanna Healthcare Holdings’ consensus price target has been raised from $8.06 to $8.81, reflecting analysts’ increased confidence driven by improved leverage visibility, regulatory resolution, operational outperformance, and upward earnings revisions.
Analyst Commentary
- Improved visibility into the company's leverage trajectory and positive impacts from interest rate swaps/caps.
- Strong year-to-date earnings performance accelerating progress toward a reasonable leverage ratio.
- Resolution of prior regulatory concerns following a "thesis changing quarter."
- Notable positive differentiation in the Medicaid market segment.
- Material upward revisions to earnings estimates due to operational outperformance.
What's in the News
- Aveanna Healthcare Holdings Inc. added to S&P Health Care Services Select Industry Index.
- Reported $153,000 in goodwill, intangible, and other long-lived asset impairment loss for the quarter, up from $80,000 a year ago.
- Raised full year 2025 revenue guidance to greater than $2.3 billion from greater than $2.15 billion.
Valuation Changes
Summary of Valuation Changes for Aveanna Healthcare Holdings
- The Consensus Analyst Price Target has risen from $8.06 to $8.81.
- The Net Profit Margin for Aveanna Healthcare Holdings has risen from 5.84% to 6.24%.
- The Future P/E for Aveanna Healthcare Holdings has risen slightly from 16.15x to 16.51x.
Disclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.